Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30078478HIVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS30059251HIVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS30059252HIVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS30059253HIVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS20011330HPVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS20036753HPVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS20056604HPVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS20015301HPVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS20038427HPVENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TVIS44011303HTLV-1ENSG00000072274.14protein_codingTFRCNoNo7037G3V0E5
P02786
TCGA Plot Options
Drug Information
GeneTFRC
DrugBank IDDB14520
Drug NameTetraferric tricitrate decahydrate
Target IDBE0008725
UniProt IDP02786
Regulation Typeligand
PubMed IDs16564538; 24310424; 25053935
CitationsHemadi M, Ha-Duong NT, El Hage Chahine JM: The mechanism of iron release from the transferrin-receptor 1 adduct. J Mol Biol. 2006 May 12;358(4):1125-36. Epub 2006 Mar 13.@@Geisser P, Burckhardt S: The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics. 2011 Jan 4;3(1):12-33. doi: 10.3390/pharmaceutics3010012.@@Waldvogel-Abramowski S, Waeber G, Gassner C, Buser A, Frey BM, Favrat B, Tissot JD: Physiology of iron metabolism. Transfus Med Hemother. 2014 Jun;41(3):213-21. doi: 10.1159/000362888. Epub 2014 May 12.
GroupsApproved
Direct Classification
SMILESO.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O
Pathways
PharmGKB
ChEMBLCHEMBL3301597